Gene Therapies
Therapy
Health

Spark Therapeutics

$100.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.46 (0.46%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ONCE and other stocks, options, ETFs, and crypto commission-free!

About ONCE

Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. Read More The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.

Employees
368
Headquarters
Philadelphia, Pennsylvania
Founded
2013
Market Cap
3.80B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
210.15K
High Today
$100.93
Low Today
$99.25
Open Price
$100.91
Volume
146.65K
52 Week High
$114.20
52 Week Low
$34.53

Collections

Gene Therapies
Therapy
Health
Research And Development
Biotechnology
Technology

ONCE Earnings

-$1.75
-$1.20
-$0.65
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$1.21 per share
Actual
Expected Aug 22, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.